Chiba, Japan

Katsuya Tsuchihara

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Kracie Pharma, Ltd., National Cancer Center, The University of Toyama. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuya Tsuchihara. Retrieved from https://idiyas.com/inventor/katsuya-tsuchihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuya Tsuchihara: Innovator in Anticancer Solutions

Introduction

Katsuya Tsuchihara, an inventive researcher located in Chiba, Japan, has made significant contributions to the field of oncology. With a focus on developing innovative anticancer therapies, he holds a unique patent aimed at enhancing cancer treatment efficacy while alleviating associated side effects. His work symbolizes the intersection of biotechnology and healthcare, paving the way for novel strategies in cancer care.

Latest Patents

Tsuchihara's notable patent is an anticancer agent that combines arctigenin with another component that also possesses anticancer properties. This invention aims to boost tumor suppression and improve the survival rates of patients. The patent outlines a combination therapy or a kit that includes formulations of arctigenin alongside its complementary anticancer agent. The synergistic effect of this combination is designed to inhibit tumor growth more effectively and decrease the percentage of cancer stem cells within tumors, ultimately enhancing patient outcomes by extending survival times and minimizing side effects.

Career Highlights

Throughout his career, Katsuya Tsuchihara has collaborated with various prestigious organizations. His association with the University of Toyama provided a strong research foundation, while his tenure at Kracie Pharma, Ltd. allowed him to translate his research into practical applications. Tsuchihara's dedication to oncology has seen him explore innovative pathways to improve cancer treatments.

Collaborations

Tsuchihara has worked alongside notable colleagues like Hiroyasu Esumi and Masafumi Ikeda. These collaborations have fostered an environment of shared knowledge and innovation, contributing to advancements in cancer therapeutic strategies.

Conclusion

Katsuya Tsuchihara's work in developing an innovative anticancer agent illustrates the potential for combining established compounds with modern treatment strategies to combat cancer more effectively. His contributions to the field highlight the vital role of inventors in the pursuit of improved healthcare solutions. Through his patents and collaborations, Tsuchihara continues to make strides toward advancing cancer treatment and improving patient quality of life.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…